Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation
暂无分享,去创建一个
P. Sonneveld | D. Reece | N. Callander | M. Shi | A. Stewart | C. Scheid | A. Spencer | C. Cai | M. Beksaç | G. Kalimi | J. Scott | A. Stewart